Novel Compound Heterozygous TMPRSS15 Gene Variants Cause Enterokinase Deficiency

Lan Wang,Dan Zhang,Cheng Fan,Xiaoying Zhou,Zhifeng Liu,Bixia Zheng,Li Zhu,Yu Jin
DOI: https://doi.org/10.3389/fgene.2020.538778
IF: 3.7
2020-09-11
Frontiers in Genetics
Abstract:<span><b>Background:</b> Enterokinase deficiency (EKD) is a rare autosomal recessively inherited disorder mainly characterized by diarrhea, hypoproteinemia and failure to thrive in infancy. Loss-of-function variants in the <i>TMPRSS15</i> gene cause EKD.<b>Methods:</b> We report the clinical manifestations and molecular basis of EKD in a Chinese child. We investigated <i>in vitro</i> two <i>TMPRSS15</i> variants: the c.1921G &gt; A as a possible splicing variant by minigene assay; the c.2396T &gt; A(p.Val799Asp) as a missense change by protein expression analysis, enterokinase activity and effect on cellular localization.<b>Results:</b> The proband presented with intractable diarrhea accompanied by vomiting, failure to thrive and hypoproteinemia in his second year. Genetic analysis showed that the patient was compound heterozygous for two variants in the <i>TMPRSS15</i> gene: c.[1921G &gt; A];[2396T &gt; A]. The c.1921 G &gt; A variant may change the glutamic acid 641 into lysine; this change is predicted to be benign by bioinformatics analysis. However, it was predicted to disrupt the splicing donor site. Our minigene assay revealed that c.1921G &gt; A caused the skipping of exon 16. The c.2396T &gt; A(p.Val799Asp) change in the serine protease domain predicted to be deleterious hitting an evolutionary conserved amino acid. Functional studies <i>in vitro</i> revealed that the p.Val799Asp variant decreased the total expression level of <i>TMPRSS15</i> by 29%, and the enterokinase activity of p.Val799Asp mutants was decreased by 37%, compared with that of wild type.<b>Conclusion:</b> We reported an EKD patient with novel compound heterozygous variants in the <i>TMPRSS15</i> gene, expanding the genotypic and phenotypic spectrum of EKD. The functional characterization <i>in vitro</i> demonstrated that the c.1921G &gt; A variant alters pre-mRNA splicing and the p.Val799Asp variant leads to a decrease in protein expression and enzyme activity.</span>
genetics & heredity
What problem does this paper attempt to address?
This paper describes a rare autosomal recessive genetic disease in Chinese children called Enterokinase Deficiency (EKD). The disease is mainly characterized by chronic diarrhea, hypoproteinemia, and growth retardation in infancy. Researchers identified two novel compound heterozygous variants, c.1921G>A and c.2396T>A, in the TMPRSS15 gene in the patients using whole-exome sequencing. These variants led to the loss of enterokinase function. The c.1921G>A variant could alter the splicing site, resulting in the skipping of exon 16. On the other hand, the c.2396T>A variant was a missense variant, affecting a highly conserved amino acid in the serine protease domain. In vitro experiments demonstrated that the p.Val799Asp variant decreased the expression level and enzymatic activity of the TMPRSS15 protein. The conclusion of the paper stated that these two newly identified TMPRSS15 gene variants expanded the genotype and phenotype spectrum of enterokinase deficiency. In vitro functional studies showed that the c.1921G>A variant altered the splicing of the precursor mRNA, while the p.Val799Asp variant led to decreased protein expression and enzymatic activity. This study provides important information for understanding the pathogenesis of enterokinase deficiency and potential future therapeutic strategies.